Brian M. Cawrse

Use of Arabinonucleosides for Development and Implementation of a Novel 2′‐O‐Protecting Group for Efficient Solid‐Phase Synthesis and 2′‐O‐Deprotection of RNA Sequences

S. Beaucage, Mayumi Takahashi, A. Grajkowski, 2022, Current protocols.

Innovative 2'-O-Imino-2-propanoate-Protecting Group for Effective Solid-Phase Synthesis and 2'-O-Deprotection of RNA Sequences.

S. Beaucage, Mayumi Takahashi, A. Grajkowski, 2021, The Journal of organic chemistry.

Structural and Biological Investigations for a Series of N-5 Substituted Pyrrolo[3,2-d]pyrimidines as Potential Anti-Cancer Therapeutics

G. M. Wilson, K. Seley‐Radtke, Brian M. Cawrse, 2019, Molecules.

An Alternate Process for the Solid‐Phase Synthesis and Solid‐Phase Purification of Synthetic Nucleic Acid Sequences

S. Beaucage, A. Grajkowski, Brian M. Cawrse, 2023, Current protocols.

Dimethylamylamine: a drug causing positive immunoassay results for amphetamines.

J. Magluilo, S. Vorce, Justin M. Holler, 2011, Journal of analytical toxicology.

Distribution of methylone in four postmortem cases.

D. Fowler, B. Levine, R. Jufer, 2012, Journal of analytical toxicology.

Anticancer Properties of Halogenated Pyrrolo[3,2‐d]pyrimidines with Decreased Toxicity via N5 Substitution

K. Seley‐Radtke, Brian M Cawrse, Rena S. Lapidus, 2018, ChemMedChem.

Antiproliferative activities of halogenated pyrrolo[3,2-d]pyrimidines.

G. M. Wilson, J. Balzarini, Christina R. Ross, 2015, Bioorganic & medicinal chemistry.